Outcomes Research Consortium - PDFSEARCH.IO - Document Search Engine

Outcomes Research Consortium
Results: 52

#	Item
11	UNIVERSITY OF MANCHESTER NATIONAL PRIMARY CARE RESEARCH AND DEVELOPMENT CENTRE AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Development feedback report on piloted indicator(s) Add to Reading List Source URL: www.nice.org.uk Language: English - Date: 2014-06-10 06:53:53 Reliability engineering Myers-Briggs Type Indicator Asthma Systems engineering Systems science National Health Service Quality and Outcomes Framework Medicine
12	UNIVERSITY OF MANCHESTER NATIONAL PRIMARY CARE RESEARCH AND DEVELOPMENT CENTRE AND UNIVERSITY OF YORK HEALTH ECONOMICS CONSORTIUM (NICE EXTERNAL CONTRACTOR) Development feedback report on piloted indicator(s) Add to Reading List Source URL: www.nice.org.uk Language: English - Date: 2014-04-04 10:39:35 Quality and Outcomes Framework Health Diabetes mellitus type 1 DESMOND Diabetes mellitus Medical terms Diabetes National Health Service Medicine
13	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI-PROTECT Benefit-Risk Group RECOMMENDATIONS REPORT Recommendations for the methodology and Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:14 Risk management Actuarial science Security Evaluation Risk assessment Natalizumab Health effects of wine Financial risk Risk Management Ethics
14	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Supplement 2 to Wave 1 Case Study Report 1:b:iii: Efalizumab Multi-Criteria Decision Analysis: Decision Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:14 Clinical research Immunosuppressants Science Efalizumab Autoimmune diseases Progressive multifocal leukoencephalopathy Psoriasis Placebo Clinical trial Medicine Health Pharmacology
15	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Supplement 1 to Wave 1 Case Study Report 1:b:iii: Raptiva® (efalizumab) Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:12 Medicine Psoriasis Centocor Health Efalizumab Ustekinumab European Medicines Agency Adalimumab Natalizumab Immunosuppressants Monoclonal antibodies Pharmacology
16	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI PROTECT WP5 IMI Report 2:b:iv NATALIZUMAB WAVE 2 CASE STUDY REPORT Review of methodologies for benefit and Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:14 Multiple sclerosis Immune system Autoimmune diseases Natalizumab Treatment of multiple sclerosis Progressive multifocal leukoencephalopathy Fingolimod JC virus Glatiramer acetate Immunology Medicine Immunosuppressants
17	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI Work Package 5: Report 1:b:iii Benefit - Risk Wave 1 Case Study Report: Raptiva® (efalizumab) Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:12 Pharmacology Monoclonal antibodies Health Recombinant proteins Efalizumab Adalimumab Psoriatic arthritis Progressive multifocal leukoencephalopathy Biologic Immunosuppressants Medicine Psoriasis
18	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium IMI WP5 Report 1:b:iv Benefit-Risk Wave 1 case study report: NATALIZUMAB Risk benefit case study with a focus on testing methodology. Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:12 Multiple sclerosis Health Autoimmune diseases Natalizumab Treatment of multiple sclerosis Progressive multifocal leukoencephalopathy Fingolimod JC virus Glatiramer acetate Immunology Medicine Immunosuppressants
19	Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium Review of visualisation methods for the representation of benefit-risk assessment of medication: Stage 1 of 2 Add to Reading List Source URL: protectbenefitrisk.eu Language: English - Date: 2014-07-16 01:09:12 Ethics Mathematics Diagram Security Risk Plot Chart Scatter plot Graph Infographics Actuarial science Management
20	State of Iowa Outcomes Monitoring System THE IOWA CONSORTIUM FOR SUBSTANCE ABUSE RESEARCH AND EVALUATION Year 16 Annual Outcome Evaluation Trend Report Add to Reading List Source URL: www.idph.state.ia.us Language: English - Date: 2015-02-03 13:27:04 Public health Drug rehabilitation Alcoholism Alcohol Pharmacology Psychiatry Substance abuse Drug addiction Alcohol abuse

UPDATE